s6y Woloson Bradford D 3

Woloson Bradford D 3, filed Aug 1, 2012: Initial statement of insider ownership

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Woloson Bradford D

(Last) (First) (Middle)
100 INTERNATIONAL DRIVE, SUITE 19100

(Street)
BALTIMORE MD 21202

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2012
3. Issuer Name and Ticker or Trading Symbol
Eloqua, Inc. [ ELOQ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock (1) (1) Common Stock 4,849,859 (1) I See footnotes(2)(3)
Series B Convertible Preferred Stock (4) (4) Common Stock 1,907,150 (4) I See footnotes(2)(3)
Series C Convertible Preferred Stock (5) (5) Common Stock 1,559,242 (5) I See footnotes(2)(3)
Explanation of Responses:
1. These securities are shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Shares") and are convertible at any time into shares of the Issuer's Common Stock at the holder's election. The Series A Shares do not have an expiration date. Upon the closing of a Qualifying U.S. Public Offering (as defined in Article Fourth, Section B.5 of the Issuer's Second Amended and Restated Certificate of Incorporation, as the same may be amended from time to time), the Series A Shares will convert at a ratio of 5-to-2, into the number of shares of Common Stock as shown in column 3.
2. As of the date hereof, JMI Equity Fund IV, L.P. ("Fund IV") owns 11,234,952 Series A Shares, 4,418,013 shares of the Issuer's Series B Convertible Preferred Stock (the "Series B Shares")and 3,612,067 shares of the Issuer's Series C Convertible Preferred Stock (the "Series C Shares"), and JMI Equity Fund IV (AI), L.P. ("Fund IV (AI)" and together with Fund IV, collectively the "Equity IV Funds") owns 889,698 Series A Shares, 349,863 Series B Shares and 286,040 Series C Shares.
3. Mr. Woloson disclaims Section 16 beneficial ownership of the Series A Shares, Series B Shares and Series C Shares held by the Equity IV Funds (collectively, the "Equity IV Fund Shares") and this report shall not be deemed an admission that such reporting person is the beneficial owner of such Equity IV Fund Shares, except to the extent of his pecuniary interest, if any, in the Equity IV Fund Shares by virtue of his membership interest in JMI Associates IV, L.L.C.
4. These securities are Series B Shares and are convertible at any time into shares of the Issuer's Common Stock at the holder's election. The Series B Shares do not have an expiration date. Upon the closing of a Qualifying U.S. Public Offering (as defined in Article Fourth, Section B.5 of the Issuer's Second Amended and Restated Certificate of Incorporation, as the same may be amended from time to time), the Series B Shares will convert at a ratio of 5-to-2, into the number of shares of Common Stock as shown in column 3.
5. These securities are Series C Shares and are convertible at any time into shares of the Issuer's Common Stock at the holder's election. The Series C Shares do not have an expiration date. Upon the closing of a Qualifying U.S. Public Offering (as defined in Article Fourth, Section B.5 of the Issuer's Second Amended and Restated Certificate of Incorporation, as the same may be amended from time to time), the Series C Shares will convert at a ratio of 5-to-2, into the number of shares of Common Stock as shown in column 3.
Remarks:
/s/ Bradford D. Woloson 08/01/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.